![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
UroGen Pharma Ltd | NASDAQ:URGN | NASDAQ | Common Stock |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
16.20 | 17.49 | 17.60 | 16.32 | 17.48 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 82.71M | -102.24M | -2.8299 | -5.82 | 595.42M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
22:12:38 | 98 | 16.12 | USD |
Date | Time | Source | Headline |
---|---|---|---|
27/7/2023 | 17:06 | DJN | UroGen Stock Up 49% on Full Enrollment for Bladder Cancer Study |
UroGen Pharma (URGN) Share Charts1 Year UroGen Pharma Chart |
|
1 Month UroGen Pharma Chart |
Intraday UroGen Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions